INTRODUCTION
With a population of over 1.35 billion, China is the world's most populous country and the second-largest country by land area, covering approximately 9.6 million square kilometers. Since the introduction of economic reforms in 1978, China has become one of the world's fastest-growing major economies and has been the second-largest economy.
At the same time, China's government funding is increasing by 20% a year, which stimulates research and development. 1 Together with other
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Tie-su Lin, Dept. of Gastroenterology and Hepatology, Dept. of Epidemiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, P.R. China. E-mail: 85997670@qq.com great motive power, China is now ranked as the highest producing country for scientific research publications since 2012. 2 In addition, there has been rapid development in the biomedical fields. [3] [4] [5] Such development has also appeared in the field of gastroenterology and hepatology, so the 2013 World Congress of Gastroenterology was held in China and more and more researchers from mainland China show their academic achievements on the international stage. Therefore, China is becoming a leading force in medical research, including gastroenterology and hepatology.
However, the impact of gastroenterology and hepatology studies from mainland China has not been investigated so far to the best of our knowledge. Since the advent of bibliometric science, citation analysis has been widely used to evaluate the influence of a scientific article, which focuses on the methodological, quality and ranking issues of authors, journals, institutions and nations. 6 Citation analysis has been performed in otolaryngologyhead and neck surgery, 7 14 Because acute pancreatitis is only one of the most common diseases in gastroenterology, so there were no gastroenterology and hepatology articles from China included in previous "mostcited" studies, and we believe perhaps no study has been performed specifically to analyze the mostcited papers in gastroenterology and hepatology from mainland China.
We therefore sought to (1) identify the 50 mostcited gastroenterology and hepatology articles originating in mainland China and (2) analyze these articles in terms of source journals, institutions and topics.
METHODS
A search was performed on March 30, 2015, using the bibliometric database Web of Science (Thomson Reuters, Philadelphia, PA, USA), a method that has been used in similar studies. 5, [14] [15] [16] [17] There were 75 journals under the subject category of "gastroenterology & hepatology" in Journal Citation Report for 2015. The four leading journals in clinical medicine were also searched, The New England Journal of Medicine, The Lancet, The Journal of the American Medical Association, and The British Medical Journal. Then articles from the 79 journals were ranked based on the number of citations. Using a previous protocol from similar studies, 5, 14 to exclude articles written outside mainland China, a filter of "Countries/ territories" was applied first by choosing "Peoples R China" in searching. To exclude other document types, "Article" was chosen. Using the platform of Pubmed, each article was evaluated and those without a primary address or a reprint address from mainland China were excluded. Following the methods of previous studies, 5, 14 basic information was collected, including the title, authors, year of publication, source journal, city, institution, number of citations, and topic of the research.
RESULTS
The 50 articles are listed in Table- I in descending order, based on the number of citations they received. The most cited article received 279 citations, and the least-cited article received 89 citations. The mean number of citations per article was 129.
These articles were published from 2005 to 2012. There were 9 oldest cited articles published in 2005. The newest article was published in 2012 and was written by Zheng Fang. 2009 was the year with the largest number of highly cited papers were published (n=13, 26%), followed by 2010 (n=12, 24%). Although there were only 4 articles published in 2007, the most cited two articles were produced. (Fig.1) The 50 top-cited articles were published in 15 journals, led by Hepatology (21 articles), followed by Journal of Gastroenterology and Hepatology(4 articles), Journal of Hepatology (4 articles) and World Journal of Gastroenterology (4 articles).
( Table- II) The top 50 articles originated from 13 Chinese cities, with Shanghai producing 20 articles, followed by Guangzhou with 13 and Beijing with 6, which were far more than other cities.
Altogether, 27 institutions produced these 50 topcited articles. Institutions associated with more than one paper were Sun Yat-sen University(n=10; 20%), Shanghai Jiao tong University (n=6; 12%), Second Military Medical University (n=5; 10%), Fudan University (n=4; 8%), Peking University (n=2, 4%), and Shanghai Second Medical University (n=2; 4%). (Table-III) The top first author was Fan Jian-Gao with three publications on the list, meanwhile the other authors were all with one article. Of the top 50 articles, 32 reported basic research and 18 were clinical studies. Hepatocellular carcinoma was the most-discussed topic(n=19, 38%), followed by hepatitis B virus (n=8, 16%), endoscopic (n=5, 10%). (Table-IV) There were limitations to our study. One was that according to the well-defined method, this study did not include gastroenterology subject articles in non-gastroenterology journals, a potential source of numerous highly cited sources. Textbooks and monographs were also not included, and although often not a source of original material, they are frequently cited. 7 Moreover, although the welldefined method was used to identify influential articles, important ones from mainland China that have been cited less often were not included. And the number of citations that an article receives is not necessarily a reflection of the quality of research. 5 Finally, using total number of citations as a standard of impact would be expected to favor older articles that accumulate a larger number of citations with time; however, we found it interesting and somewhat counterintuitive that the most recent decade in our search garnered the largest number of top-cited articles. 5 In general, as shown in Fig.2 , the total number of citations of 50 top-cited articles in gastroenterology and hepatology from mainland China in every year is gradually rising. This reflects that research coming from mainland China is Sun-kuan Hu et al. 
DISCUSSION
There is no doubt that citation analysis can supply quantitative information about journals, institutions, authors which is helpful to identify classic works and high-impact journals. It can also help us recognize important advances in research and add useful perspective on historical developments in our field.
14 Although citation analysis of the top cited articles has been performed in multiple medical fields, 5, [7] [8] [9] [10] 13, 14 to the best of our knowledge, this is the first bibliometric analysis to reveal the top citations from mainland China in the field of research about gastroenterology and hepatology. 4 gaining visibility and impact in more recent years. The top 50 articles were cited between 89 and 279 times, which are obviously lower than those of global gastroenterology and hepatology research field, where the citation numbers were between 1383 and 4827. Based on this data, it is not surprising that there was no Chinese article appearing in the 50 top-cited articles list. Although these Chinese articles were not as approbatory as the ones from other countries by experts in gastroenterology and hepatology, they were recognized by the authoritative journals. It is no doubt that Gastroenterology, Gut and Hepatology are journals with most high impact factor, which published 52% (n=26) of the 50 topcited articles from mainland China. (Table-II) However, there were 86% (n=43) of the top-cited articles from global community published in these three journals, which shows that there is still a need to improve the quality of Chinese research.
Thirteen cities contributed to the top 50 list of highest cited articles, led by Shanghai, Guangzhou and Beijing, and of which the number was far more than other cities. This finding confirms the cities' overwhelming impact on medical science research because of its large population and the abundant financial resources available to the scientific community.
14 Our top-50 list included more basic research articles than clinical studies, of which the ratio was approximately 1.78(32:18) . This ratio was much more higher than the average ratio (1.31:1, range 0.7:1-1.5:1) of Chinese clinical research, 3 caused by several reasons. Firstly, it is influenced by the characteristic of clinical studies, which needs long time treatment and complex follow up. Secondly, compared to western-style health-care 18 system, it is lack of sound information and not convenience in mainland China, which has impact on the quality of clinical subjects. Finally, insufficient funding, lack of available time, an unsupportive research environment, and a deficient clinical research teaching program are also important and complex factors leading to fewer clinical studies. 19 Of the 50 top-cited articles, Hepatocellular carcinoma and hepatitis B virus related articles accounted for more than 50%(27/50). This may be connected with the high incidence rate of these diseases. In China, there were approximately 93 million people infected with HBV, which was indicated by an epidemiologic serosurvey of hepatitis B that the weighted prevalence of HBsAg in the Chinese population aged 1-59 years was 7.2%. 20, 21 The spectrum of disease and natural history of chronic HBV infection are diverse and variable, ranging from an inactive carrier state to progressive chronic hepatitis B (CHB), which may evolve to cirrhosis and hepatocellular carcinoma (HCC). 22 All over the world, approximately 75% of liver cancer occurs in Asia, with China accounting for more than 50% of the world's burden. 23, 24 Fortunately, the incidence of hepatitis B virus is decreasing gradually in China, which is because of programs to reduce aflatoxin B1 (AFB1) exposure and hepatitis B virus (HBV) transmission and other public health efforts. 25 These are strong indications that Chinese medical workers in gastroenterology and hepatology not only give their contributions to preventing and curing hepatocellular carcinoma and hepatitis B virus, but also their related studies are recognized by the world.
In addition, there were five articles about endoscopic and published in Endoscopy, American Journal of Gastroenterology, and Gastrointestinal Endoscopy, which improved that much progress in GI endoscopy has been made by Chinese endoscopists, the efforts and achievements have gradually gained international recognition.
Citation frequency is by no means a perfect measure of scientific impact, but considered as one of several valid and legitimate indicators in identifying classic work. Compared to the global community, the gastroenterology and hepatology research in mainland China remains having lower impact. But the authors of these top-cited 50 articles should be proud of their achievements, they were the representative of efforts made in gastroenterology and hepatology of mainland China in recent 60 years, which was gradually being recognized by the world.
